Samit Hirawat - EVP,Chief Med.Offr.,Drug Dev. at BRISTOL MYERS SQUIBB CO

Issuer-level insider activity

Role
EVP,Chief Med.Offr.,Drug Dev.
Issuer ticker
BMY, CELG-RI on NYSE
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Samit Hirawat since 08 Sep 2025

Reported holdings for Samit Hirawat in BRISTOL MYERS SQUIBB CO

Form 4 holding EVP,Chief Med.Offr.,Drug Dev.

BRISTOL MYERS SQUIBB CO

Security class
Market Share Units
Shares / value
35,146
Estimated value
$1,862,387
Report date
10 Mar 2025
Price
$52.99
Ownership
Direct
Underlying class
Common Stock, $0.10 par value
Underlying amount
Form 4 holding EVP,Chief Med.Offr.,Drug Dev.

BRISTOL MYERS SQUIBB CO

Security class
Performance Shares
Shares / value
52,720
Estimated value
Report date
10 Mar 2025
Price
Ownership
Direct
Underlying class
Common Stock, $0.10 par value
Underlying amount

Transaction history for Samit Hirawat in BRISTOL MYERS SQUIBB CO

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .